Efficacy and safety of CHG regimen (low-dose cytarabine, homoharringtonine with G-CSF priming) as induction chemotherapy for elderly patients with high-risk MDS or AML transformed from MDS

被引：0
|
作者：
Lingyun Wu
Xiao Li
Jiying Su
Qi He
Xi Zhang
Chunkang Chang
Quan Pu
机构：
[1] The Sixth Hospital Affiliated to Shanghai Jiaotong University,Department of Hematology
来源：
Journal of Cancer Research and Clinical Oncology | 2011年 / 137卷
关键词：
Myelodysplastic syndromes; Acute myeloid leukemia; Cytarabine; Homoharringtonine; Granulocyte colony-stimulating factor (G-CSF);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1563 / 1569
页数：6
相关论文
共 50 条
  • [1] Efficacy and safety of CHG regimen (low-dose cytarabine, homoharringtonine with G-CSF priming) as induction chemotherapy for elderly patients with high-risk MDS or AML transformed from MDS
    Wu, Lingyun
    Li, Xiao
    Su, Jiying
    He, Qi
    Zhang, Xi
    Chang, Chunkang
    Pu, Quan
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (10) : 1563 - 1569
  • [2] The efficacy and toxicity of the CHG priming regimen (low-dose cytarabine, homoharringtonine, and G-CSF) in higher risk MDS patients relapsed or refractory to decitabine
    Cai Xiu
    Xiao Li
    Lingyun Wu
    Feng Xu
    Qi He
    Zheng Zhang
    Dong Wu
    Luxi Song
    Jiying Su
    Liyu Zhou
    Youshan Zhao
    Ying Tao
    Chunkang Chang
    Journal of Cancer Research and Clinical Oncology, 2019, 145 : 3089 - 3097
  • [3] The efficacy and toxicity of the CHG priming regimen (low-dose cytarabine, homoharringtonine, and G-CSF) in higher risk MDS patients relapsed or refractory to decitabine
    Xiu, Cai
    Li, Xiao
    Wu, Lingyun
    Xu, Feng
    He, Qi
    Zhang, Zheng
    Wu, Dong
    Song, Luxi
    Su, Jiying
    Zhou, Liyu
    Zhao, Youshan
    Tao, Ying
    Chang, Chunkang
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (12) : 3089 - 3097
  • [4] Efficacy and Safety of Decitabine in Combination with G-CSF, Low-Dose Cytarabine and Aclarubicin in MDS-EB and AML-MRC
    Liu, Jing
    Jia, Jinsong
    Gong, Li-Zhong
    Lu, Shen-ye
    Zhu, Hong-Hu
    Huang, Xiao-Jun
    Jiang, Hao
    BLOOD, 2017, 130
  • [5] EFFICACY OF LOW-DOSE CYTARABINE-BASED REGIMEN(CAG) FOLLOWED BY AZACITIDINE FOR ELDERLY PATIENTS WITH MDS/AML
    Tabayashi, Takayuki
    Takahashi, Yasuyuki
    Kimura, Yuta
    Tomikawa, Tatsuki
    Sagawa, Morihiko
    Anan, Tomoe
    Watanabe, Reiko
    Tokuhira, Michihide
    Mori, Shigehisa
    Kizaki, Masahiro
    ANNALS OF ONCOLOGY, 2014, 25
  • [6] Decitabine in combination with low-dose cytarabine, aclarubicin and G-CSF tends to improve prognosis in elderly patients wan high-risk AML
    Hong, Ming
    Zhu, Han
    Sun, Qian
    Zhu, Yu
    Miao, Yi
    Yang, Hui
    Qiu, Hai-Rong
    Li, Jian-Yong
    Qian, Si-Xuan
    AGING-US, 2020, 12 (07): : 5792 - 5811
  • [7] Priming GM-CSF and low dose cytarabine (LODAC) in the treatment of high risk and elderly acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS) patients.
    Winer, ES
    Miller, KB
    Chan, GW
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 585S - 585S
  • [8] ORAL CLOFARABINE PLUS LOW-DOSE CYTARABINE IN PREVIOUSLY TREATED AML AND HIGH-RISK MDS PATIENTS=60 YEARS OF AGE
    Pagel, M.
    Sandhu, R.
    Gooley, T.
    Scott, B.
    Shannon-Dorcy, K.
    Dean, C.
    Appelbaum, R.
    Estey, H.
    HAEMATOLOGICA, 2012, 97 : 29 - 29
  • [9] Efficacy and Safety of Decitabine in Combination with G-CSF, Low-Dose Cytarabine and Mitoxantrone in Pediatric Refractory and Relapse Acute Myeloid Leukemia and MDS-Raebt
    Fan, Liyan
    Chen, Aili
    Hu, Yixin
    Xiao, Peifang
    Lu, Jun
    Li, Jie
    He, Hailong
    Wang, Yi
    Hu, Shaoyan
    BLOOD, 2018, 132
  • [10] Intensive chemotherapy with idarubicin, ARA-C, etoposide, and G-CSF priming yields high complete remission rates and is well tolerated in patients with advanced mds and high-risk AML (AML-MDS-STUDY02/95).
    Ganser, A
    Hofmann, WK
    Heil, G
    Wittwer, S
    Zander, C
    Ottmann, OG
    Bergmann, L
    Hoeffken, K
    Fischer, JT
    Knuth, A
    Kolbe, K
    Schmoll, HJ
    Langer, W
    Westerhausen, M
    Koelbel, CB
    Hoelzer, D
    BLOOD, 1999, 94 (10) : 299A - 299A
12345